Table 1. Annual burden of mortality, disease incidence and years of life lost (YLL) attributable to tobacco, by cause and country for 2020.
| Deaths | Argentina | Brazil | Chile | Colombia | Costa Rica | Ecuador | Mexico | Peru | Total |
| CV disease | 10 045 (22.4%) | 33 179 (20.5%) | 2986 (15.6%) | 7952 (26.2%) | 519 (23.9%) | 1451 (21.3%) | 19 529 (30.9%) | 2252 (10.1%) | 77 914(22.2%) |
| Stroke | 2175 (4.9%) | 10 041 (6.2%) | 1249 (6.5%) | 1656 (5.5%) | 94 (4.3%) | 471 (6.9%) | 4093 (6.5%) | 1538 (6.9%) | 21 317(6.1%) |
| COPD | 9117 (20.4%) | 37 686 (23.3%) | 5731 (30.0%) | 8539 (28.1%) | 628 (28.9%) | 2010 (29.5%) | 17 218 (27.3%) | 7625 (34.1%) | 88 554(25.3%) |
| Pneumonia | 3928 (8.8%) | 12 201 (7.5%) | 701 (3.7%) | 783 (2.6%) | 97 (4.5%) | 514 (7.6%) | 4080 (6.5%) | 2875 (12.8%) | 25 180(7.2%) |
| Lung cancer | 8591 (19.2%) | 24 443 (15.1%) | 3221 (16.8%) | 4337 (14.3%) | 254 (11.7%) | 680 (10.0%) | 5122 (8.1%) | 2420 (10.8%) | 49 068(14.0%) |
| Other cancers | 5752 (12.9%) | 25 683 (15.9%) | 3038 (15.9%) | 3584 (11.8%) | 332 (15.3%) | 898 (13.2%) | 5849 (9.3%) | 3090 (13.8%) | 48 226(13.8%) |
| Secondhand smoke | 5149 (11.5%) | 18 620 (11.5%) | 2201 (11.5%) | 3491 (11.5%) | 250 (11.5%) | 783 (11.5%) | 7266 (11.5%) | 2574 (11.5%) | 40 334(11.5%) |
| Total | 44 758(100%) | 161 853(100%) | 19 128(100%) | 30 341(100%) | 2174(100%) | 6807(100%) | 63 157(100%) | 22 374(100%) | 350 593(100%) |
| Disease events | |||||||||
| CV disease | 61 512 (27.2%) | 444 953 (40.0%) | 31 345 (26.0%) | 45 463 (27.6%) | 7662 (45.5%) | 16 437 (32.3%) | 138 841 (32.4%) | 9396 (7.4%) | 755 611(33.6%) |
| Stroke | 11 404 (5.0%) | 52 737 (4.7%) | 12 581 (10.4%) | 16 636 (10.1%) | 372 (2.2%) | 3845 (7.6%) | 34 727 (8.1%) | 10 655 (8.4%) | 142 957(6.4%) |
| COPD | 101 695 (44.9%) | 433 729 (39.0%) | 62 745 (52.0%) | 85 605 (52.0%) | 7158 (42.5%) | 23 818 (46.8%) | 196 491 (45.8%) | 74 959 (59.1%) | 986 200(43.9%) |
| Pneumonia | 32 687 (14.4%) | 114 978 (10.3%) | 5529 (4.6%) | 6836 (4.1%) | 773 (4.6%) | 4748 (9.3%) | 43 945 (10.2%) | 24 169 (19.1%) | 233 665(10.4%) |
| Lung cancer | 9538 (4.2%) | 26 126 (2.3%) | 3696 (3.1%) | 4652 (2.8%) | 322 (1.9%) | 755 (1.5%) | 6060 (1.4%) | 2730 (2.2%) | 53 880(2.4%) |
| Other cancers | 9654 (4.3%) | 40 261 (3.6%) | 4840 (4.0%) | 5589 (3.4%) | 567 (3.4%) | 1322 (2.6%) | 9002 (2.1%) | 4845 (3.8%) | 76 081(3.4%) |
| Total | 226 490(100%) | 1 112 785(100%) | 120 736(100%) | 164 782(100%) | 16 855(100%) | 50 926(100%) | 429 066(100%) | 126 754(100%) | 2 248 394(100%) |
| YLL | |||||||||
| YLL due to premature mortality | |||||||||
| CV disease | 248 276 (22.3%) | 981 080 (22.5%) | 71 643 (16.0%) | 159 276 (23.2%) | 13 260 (25.1%) | 38 746 (22.6%) | 500 288 (31.4%) | 53 255 (10.3%) | 2 065 824(23.1%) |
| Stroke | 68 787 (6.2%) | 327 639 (7.5%) | 33 411 (7.5%) | 50 428 (7.3%) | 2683 (5.1%) | 15 253 (8.9%) | 123 195 (7.7%) | 42 520 (8.3%) | 663 916(7.4%) |
| COPD | 217 999 (19.5%) | 923 920 (21.2%) | 134 023 (30.0%) | 189 782 (27.6%) | 14 865 (28.1%) | 48 293 (28.2%) | 407 178 (25.5%) | 173 354 (33.6%) | 2 109 413(23.6%) |
| Pneumonia | 74 253 (6.7%) | 261 012 (6.0%) | 11 282 (2.5%) | 14 975 (2.2%) | 1961 (3.7%) | 10 391 (6.1%) | 91 872 (5.8%) | 50 199 (9.7%) | 515 945(5.8%) |
| Lung cancer | 218 342 (19.6%) | 613 890 (14.1%) | 70 941 (15.9%) | 102 710 (15.0%) | 5624 (10.6%) | 15 062 (8.8%) | 122 531 (7.7%) | 56 575 (11.0%) | 1 205 674(13.5%) |
| Other cancers | 158 666 (14.2%) | 747 008 (17.1%) | 74 166 (16.6%) | 90 123 (13.1%) | 8292 (15.7%) | 23 343 (13.6%) | 163 924 (10.3%) | 80 529 (15.6%) | 1 346 051(15.1%) |
| Secondhand smoke | 129 244 (11.6%) | 504 482 (11.6%) | 51 410 (11.5%) | 79 347 (11.6%) | 6188 (11.7%) | 20 049 (11.7%) | 186 397 (11.7%) | 58 926 (11.4%) | 1 036 042(11.6%) |
| Total premature mortality | 1 115 566(100%) | 4 359 030(100%) | 446 875(100%) | 686 641(100%) | 52 873(100%) | 171 137(100%) | 1 595 386(100%) | 515 357(100%) | 8 942 865(100%) |
| YLL due to disability | |||||||||
| CV disease | 32 951 (10.7%) | 318 543 (19.9%) | 20 972 (11.0%) | 22 730 (8.9%) | 2384 (10.0%) | 17 962 (24.3%) | 107 197 (17.5%) | 9956 (5.0%) | 532 695(16.3%) |
| Stroke | 22 180 (7.2%) | 111 747 (7.0%) | 23 544 (12.4%) | 38 579 (15.1%) | 648 (2.7%) | 7541 (10.2%) | 70 716 (11.5%) | 26 697 (13.4%) | 301 653(9.2%) |
| COPD | 152 870 (49.5%) | 634 656 (39.7%) | 94 419 (49.6%) | 139 976 (54.9%) | 10 562 (44.5%) | 34 058 (46.1%) | 288 704 (47.1%) | 122 076 (61.1%) | 1 477 320(45.3%) |
| Pneumonia | 98 (0.0%) | 345 (0.0%) | 17 (0.0%) | 21 (0.0%) | 02 (0.0%) | 14 (0.0%) | 132 (0.0%) | 73 (0.0%) | 701(0.0%) |
| Lung cancer | 32 666 (10.6%) | 137 949 (8.6%) | 12 015 (6.3%) | 10 565 (4.1%) | 2508 (10.6%) | 1618 (2.2%) | 26 460 (4.3%) | 6301 (3.2%) | 230 081(7.1%) |
| Other cancers | 32 673 (10.6%) | 211 429 (13.2%) | 17 594 (9.2%) | 13 801 (5.4%) | 4848 (20.4%) | 4038 (5.5%) | 47 651 (7.8%) | 11 933 (6.0%) | 343 968(10.5%) |
| Secondhand smoke | 35 587 (11.5%) | 183 828 (11.5%) | 21 752 (11.4%) | 29 371 (11.5%) | 2775 (11.7%) | 8677 (11.7%) | 71 543 (11.7%) | 22 765 (11.4%) | 376 297(11.5%) |
| Total disability | 309 025(100%) | 1 598 497(100%) | 190 312(100%) | 255 042(100%) | 23 727(100%) | 73 909(100%) | 612 402(100%) | 199 801(100%) | 3 262 715(100%) |
| YLL due to premature mortality | 1 115 566 (78.3%) | 4 359 030 (73.2%) | 446 875 (70.1%) | 686 641 (72.9%) | 52 873 (69.0%) | 171 137 (69.8%) | 1 595 386 (72.3%) | 515 357 (72.1%) | 8 942 865(73.3%) |
| YLL due to disability | 309 025 (21.7%) | 1 598 497 (26.8%) | 190 312 (29.9%) | 255 042 (27.1%) | 23 727 (31.0%) | 73 909 (30.2%) | 612 402 (27.7%) | 199 801 (27.9%) | 3 262 715(26.7%) |
| Total YLL | 1 424 591(100%) | 5 957 526(100%) | 637 187(100%) | 941 683(100%) | 76 600(100%) | 245 046(100%) | 2 207 788(100%) | 715 158(100%) | 12 205 580(100%) |
COPD, chronic obstructive pulmonary disease; CV, cardiovascular